T1D Strong DNA test has been awarded at ADA 2024 conference

Every year, at the ADA’s Scientific Sessions, its Innovation Challenge invites emerging companies to pitch ideas that address everyday problems faced by people with diabetes, their families, and their caregivers. Startups worldwide compete to receive financial backing and showcase their work to a panel of expert judges and professionals (endocrinologists, researchers, nurses, pharmaceutical industry leaders, and diabetes educators). We are thrilled to be selected as one of the top 10 finalists and showcase our project at the conference!